Self-expandable stents are special medical devices used for esophageal, tracheobronchial, duodenal, biliary, and colonic placement. Most of the stents are permanent and some are inserted in the body during palliative surgeries. Stenting helps in removing the blockages in the carotid artery that supplies blood to the brain. However, few stenting techniques increase the risk of both short- and long-term adverse outcomes. Carotid artery stenting is an optional procedure that can be used if a patient has 60% to 70% narrowing and has low risk of serious problems from stenting. Stents are configured into a cylinder by interwoven wires and are deployed from a constrained position within a delivery catheter. Stent diameter as well as length vary in size due to increase in the duration of stent patency. Self-expanding stents vary in design, and many stents are preloaded with a drug delivery systems. The entire system of drug delivery through stents is advanced which is carried out using guidewires through endoscope channel and fluoroscopic guidance. Characteristics such as visibility of stents under X-ray, scaffolding design for more effective drug elution and easier deliverability, and conformity of the stent struts to the vessel walls are increasing the safety and efficacy of the devices. However, new developments in stents technology are paving the way for early diagnosis and treatment of cardiovascular diseases.

High prevalence of diseases such as cardiovascular diseases and tracheoesophageal fistulas, large geriatric population with bypass surgery, rise in patient awareness programs, surge in research and development initiatives for heart diseases, increase in demand for diagnostic imaging devices are the key factors driving the global self-expandable stents market. According to the WHO, cardiovascular diseases are the leading cause of death globally. In 2016, cardiovascular diseases accounted for 37% of the 16 million deaths under the age of 70 years caused due to non-communicable diseases. Advancement in technologies such as biochips, catheter implantation, strut design of stents, and increase in use of advanced software applications available for measuring the movement of stents during treatment are likely to fuel the growth of the global self-expandable stent market. However, ability to reposition and visibility under fluorescence light are expected to increase adoption of these devices for various surgical treatments in the near future.

The global self-expandable stents market can be segmented based on product type, material, end-user, and region. In terms of product type, the market can be classified into gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents, and others. Carotid self-expandable stents is the fastest growing segment, driven by increase in prevalence of cardiovascular disease across the globe. According to the WHO, cardiovascular diseases accounted for 17.5 million deaths in 2012, representing 31% of all the global deaths. Of these, an estimated 7.4 million were due to coronary heart disease and 6.7 million due to stroke. Based on material, the global self-expandable stents market can be categorized into metal, polymer, and others. The metal segment can be divided into nitinol self-expandable stents, cobalt chromium self-expandable stents, and others. In terms of end-user, the market can be classified into ambulatory surgical units, hospitals, clinics, and others.

Geographically, the global self-expandable stents market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global self-expandable stent market due to sophisticated infrastructure with modern software modalities, patient awareness programs, and high per capita health care expenditure. Early-phase diagnosis and treatment of disease drives the medical devices market which in turn is expected to propel the self-expandable stents market in North America. Europe is the second largest market for cardiac ultrasound transducers due to favorable government policies for health care infrastructure, high incidence of cardiac diseases, and awareness among the population. The market in Asia Pacific is expected to grow at a rapid pace due to increase in geriatric population, rise in prevalence of ischemic heart disease and gastroenterology disorders, changing lifestyle, surge in awareness among patients about cardiovascular diseases, and increase in per capita expenditure. Additionally, economic growth supports improvement of the health care infrastructure in developing countries such as India and China. Hence, these factors contribute to the growth of the self-expandable stents market in Asia Pacific.

Major players operating in the global self-expandable stents market include W. L. Gore & Associates, Terumo Corporation, Boston Scientific Corporation, Abbott, InspiredMD, Medtronic, Cordis (Cardinal Health), Cook Medical, CeloNova BioSciences, Inc., CONMED Corporation, and MicroPort Scientific Corporation.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Self Expandable Stents Market

Pre Book